The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI.
BMC Cancer. 2017 Dec 28;17(1):893. doi: 10.1186/s12885-017-3918-9.
BMC Cancer. 2017.
PMID: 29282088
Free PMC article.
Clinical Trial.